| 英文名称 |
中文名称 |
CAS |
|
2-Ethoxy-3-acetonyltaxifolin
|
|
2212305-01-4 |
|
Kushenol W
|
|
254886-76-5 |
|
YHO-13177；YHO13177;YHO 13177
|
|
912287-56-0 |
|
11-Hydroxycanthin-6-one
|
|
75969-83-4 |
|
1-Hydroxy-9-medroxycanthin-6-one
|
|
622408-85-9 |
|
25-O-ethylcimigenol-3-O-beta-D-xylopyranoside
|
|
914086-57-0 |
|
6-Hydroxykaempferol 3,6-diglucoside
|
|
142674-16-6 |
|
(3R)-7,4’-Dihydrohomoisoflavanone；7,4'-Dihydroxyhomoisoflavanone
|
|
1178893-64-5 |
|
9-Angeloylretronecine N-oxide
|
|
27773-86-0 |
|
Acetylvirolin
|
|
916264-22-7 |
|
Diacetoxy-6-gingerdiol
|
|
143615-75-2 |
|
Glychionide A
|
|
119152-50-0 |
|
Interiotherin C
|
|
460090-65-7 |
|
Isosalvianolic acid C
|
|
142115-17-1 |
|
Kuraridine
|
|
34981-25-4 |
|
(Z)-Mirin；Mirin
|
|
1198097-97-0 |
|
Peucedanocoumarin II
|
|
130464-56-1 |
|
Syringaresinol
|
|
487-35-4 |
|
Taxuspine B
|
|
157414-05-6 |
|
Angelicolide
|
|
90826-58-7 |
|
Vinaginsenoside R4
|
|
156009-80-2 |
|
Bayogenin 3-O-β-D-glucopyranoside；Bayogenin 3-O-beta-D-glucopyranoside
|
|
104513-86-2 |
|
Euojaponine D
|
|
128397-42-2 |
|
PFI-2 hydrochloride；(R)-PFI-2 hydrochloride;PFI-2 HCl
|
|
1627607-87-7 |
|
RO8994
|
|
1309684-94-3 |
|
Bancroftinone
|
|
14964-98-8 |
|
Alofanib；RPT835
|
|
1612888-66-0 |
|
GFT505；Elafibranor
|
|
824932-88-9 |
|
Olmutinib；BI 1482694;HM61713, BI 1482694;HM61713
|
|
1353550-13-6 |
|
Glucoerucin
|
|
15592-37-7 |
|
Glucosinalbate potassium；Sinalbin potassium salt
|
|
16411-05-5 |
|
3-O-Acetyl-16α-hydroxydehydrotrametenolic acid；3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid
|
|
168293-14-9 |
|
Macrostemonoside J
|
|
159935-09-8 |
|
Ophiopogonoside A
|
|
791849-22-4 |
|
Acetyl hexapeptide 38
|
|
1400634-44-7 |
|
SP-13786；UAMC-1110
|
|
1448440-52-5 |
|
PLX8394
|
|
1393466-87-9 |
|
Methylnissolin
|
|
733-40-4 |
|
14-Norpseurotin A
|
|
1031727-34-0 |
|
2'-O-Methylbroussonin A
|
|
127757-13-5 |
|
6-epi-Albrassitriol
|
|
178456-58-1 |
|
Bakkenolide IIIa
|
|
915289-60-0 |
|
Octadecyl p-coumarate
|
|
72943-88-5 |
|
SW044248
|
|
522650-83-5 |
|
Cantabiline sodium；Hymecromone sodium;LM 94 sodium
|
|
5980-33-6 |
|
YK-3-237；B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid
|
|
1215281-19-8 |
|
A-1331852；A1331852;A 1331852
|
|
1430844-80-6 |
|
m-Terphenyl；AI3 00860;AI300860;AI3-00860
|
|
92-06-8 |
|
β-Glycerophosphate disodium salt hydrate
|
|
154804-51-0 |
|
1,4-Dibenzyloxybenzene
|
|
621-91-0 |
|
AKBA；3-O-Acetyl-11-keto-beta-boswellic acid;Acetyl-11-keto-β-boswellic acid;3-O-Acetyl-11-keto-β-boswellic acid
|
|
67416-61-9 |
|
Fandosentan potassium；PD 180988;UNII-14U0D2SA4K;PD 180988-0016
|
|
221246-12-4 |
|
Alcesefoliside
|
|
124151-38-8 |
|
Gemigliptin Tartrate(911637-19-9 free base)；LC15-0444 tartrate
|
|
1374639-74-3 |
|
Perisesaccharide C
|
|
1311473-28-5 |
|
MI-136；MI 136;MI136
|
|
1628316-74-4 |
|
PF-04929113 Mesylate；PF-04929113 (Mesylate);SNX-5422 Mesylate
|
|
1173111-67-5 |
|
Upadacitinib tartrate；ABT 494;ABT494;ABT-494
|
|
1607431-21-9 |
|
Olodanrigan；PD-126055;EMA401
|
|
1316755-16-4 |
|
CP21R7；CP21
|
|
125314-13-8 |
|
EAI045
|
|
1942114-09-1 |
|
I-BRD9；GSK602
|
|
1714146-59-4 |
|
TA-02；TA 02;TA02
|
|
1784751-19-4 |
|
Oclacitinib maleate；PF-03394197;PF-03394197 maleate
|
|
1640292-55-2 |
|
GAL-021；GAL 021;GAL021
|
|
1380341-99-0 |
|
CPI-455；CPI-455 HCl;CPI 455;CPI455
|
|
1628208-23-0 |
|
Tomivosertib；eFT508
|
|
1849590-01-7 |
|
CBL0137；Curaxin 137;CBLC137
|
|
1197996-80-7 |
|
6-hydroxyl kaempherol-3,6-O-diglucosyl-7-O-Glucuronic acid
|
|
307950-53-4 |
|
Atorvastatin, (3S,5R)-；AT10 Trans
|
|
887324-52-9 |
|
PZM21
|
|
1997387-43-5 |
|
Epelsiban besylate；GSK557296B;GSK-557296B
|
|
1159097-48-9 |
|
GSK1940029；SCD inhibitor 1
|
|
1150701-66-8 |
|
TP-2857；TAP2857
|
|
1575491-01-8 |
|
GDC-0575；RG7741;ARRY-575
|
|
1196541-47-5 |
|
Seladelpar；MBX 8025
|
|
851528-79-5 |
|
Phenol, m-(2-(dipropylamino)ethyl)-, hydrobromide
|
|
64656-40-2 |
|
iMDK
|
|
881970-80-5 |
|
Suprafenacine；N'-[(E)-(4-methylphenyl)methylidene]-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide
|
|
1477482-50-0 |
|
BMS-779788；EXEL04286652;BMS-788;XL652;XL 652;XL-652
|
|
918348-67-1 |
|
CZ415
|
|
1429639-50-8 |
|
JNJ-47965567；JNJ-479655
|
|
1428327-31-4 |
|
S63845
|
|
1799633-27-4 |
|
MNS
|
|
1485-00-3 |
|
CAY10698
|
|
684236-01-9 |
|
iKIX1
|
|
656222-54-7 |
|
ML-184；CID2440433
|
|
794572-10-4 |
|
Syk Inhibitor II
|
|
726695-51-8 |
|
VLX600
|
|
327031-55-0 |
|
THZ531
|
|
1702809-17-3 |
|
HT-2157；SNAP-37889;SNAP37889;HT2157
|
|
303149-14-6 |
|
CeMMEC13
|
|
1790895-25-8 |
|
SF2523
|
|
1174428-47-7 |
|
Clematomandshurica saponin C；Clematiunicinoside E
|
|
916649-92-8 |
|
Lucyoside B
|
|
91174-19-5 |
|
N-piperidine Ibrutinib
|
|
330785-90-5 |
|
NCT-503；NCT 503;NCT503
|
|
1916571-90-8 |
|
KYA1797K
|
|
1956356-56-1 |
|
Saccharin 1-methylimidazole；SMI;Saccharin 1-methylimidazole (SMI)
|
|
482333-74-4 |
|
Arbutamine hydrochloride
|
|
125251-66-3 |
